You are here

Article Text

Article menu

See original article:

Download PDFPDF
PostScript
Letters to the Editor
Mechanical thrombectomy cannot be considered as first-line treatment for cerebral venous thrombosis
  1. J M Coutinho1,
  2. R van den Berg2,
  3. S M Zuurbier1,
  4. C B Majoie2,
  5. J Stam1
  1. 1Department of Neurology, Academic Medical Center, Amsterdam, The Netherlands
  2. 2Department of Radiology, Academic Medical Center, Amsterdam, The Netherlands
  1. Correspondence to Jonathan Coutinho, Department of Neurology, Academic Medical Center, Meivergdreef 9, Amsterdam 1105 AZ, The Netherlands; j.coutinho{at}amc.uva.nl

https://doi.org/10.1136/neurintsurg-2012-010331

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    The paper by Dashti et al1 describes 13 patients who received mechanical thrombectomy with the AngioJet device as first-line treatment for cerebral venous thrombosis (CVT). Mechanical thrombectomy is a promising alternative to endovascular thrombolysis with thrombolytic drugs. Hemorrhagic infarcts are common among patients with CVT and it is plausible—although unproven—that mechanical thrombectomy gives fewer hemorrhagic complications.

    There are, however, some issues that render the authors' suggestion to use mechanical thrombectomy as a first-line treatment …

    View Full Text

    Footnotes

    • Competing interests None.

    • Provenance and peer review Not commissioned; internally peer reviewed.

    Linked Articles